Dental status of patients with new coronavirus infection COVID-19
- Authors: Remizova A.A.1, Dzgoeva M.G.1, Tingaeva Y.I.1, Remizov N.O.2, Marin G.G.3, Medvedeva E.A.2
-
Affiliations:
- North Ossetian State Medical Academy
- A.I. Yevdokimov Moscow State University of Medicine and Dentistry
- Russian Medical Academy for Continuous Professional Education
- Issue: Vol 24, No 1 (2024)
- Pages: 37-42
- Section: DENTISTRY
- URL: https://ogarev-online.ru/2410-3764/article/view/263401
- DOI: https://doi.org/10.35693/AVP562724
- ID: 263401
Cite item
Full Text
Abstract
Aim – to clarify the clinical symptoms of COVID-19 in patients with the new coronavirus infection.
Material and methods. A total of 156 patients undergoing treatment in COVID-hospitals were included in the study. The patients were examined for the prevalence of COVID-19 clinical symptoms, COVID-19 clinical manifestations in the oral cavity and concomitant diseases.
Results. In the structure of general symptoms, the complaints of hyperthermia, general weakness and cough (more often dry) played a leading role. These symptoms were noted in the overwhelming majority of the examined patients. Two-thirds of patients reported body pain. The leading symptoms were also anosmia (in 68.6% of cases) and sweating (64.1%). More than half of the patients complained of shortness of breath (60.2%), difficulty in nasal breathing (55.1%), a feeling of tickling (58.3%) and pain (60.2%) in the throat. Among dental pathology, the loss of taste (57.5%) and hyposalivation (38.5%) were most common in patients. Bleeding gums were detected in 22.4% of the examined patients, which was most likely due to violations of the rheological properties of blood and changes in the hemodynamic provision of the parodontium during COVID-19.
Conclusion. The hemostasis disorders characteristic of the new COVID-19 infection certainly influenced the dental status, further destroying periodontal tissues. However, clinical manifestations of pathological effects might not occur immediately, but in the form of long-term complications. In this regard, it is necessary to dynamically monitor the patients who have undergone COVID-19.
Full Text
##article.viewOnOriginalSite##About the authors
Anna A. Remizova
North Ossetian State Medical Academy
Email: annasas@mail.ru
ORCID iD: 0000-0001-8471-0146
PhD, Associate professor, Head of the Department of Dentistry №3
Russian Federation, VladikavkazMadina G. Dzgoeva
North Ossetian State Medical Academy
Author for correspondence.
Email: madina-dzgoeva@mail.ru
ORCID iD: 0000-0002-0247-1901
PhD, Associate professor, Head of the Department of Dentistry №1
Russian Federation, VladikavkazYuliya I. Tingaeva
North Ossetian State Medical Academy
Email: iulia.919@yandex.ru
Resedent of the Department of Dentistry №3
Russian Federation, VladikavkazNickolai O. Remizov
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
Email: nikolajn971@gmail.com
ORCID iD: 0000-0002-7596-0618
a student
Russian Federation, MoscowGerman G. Marin
Russian Medical Academy for Continuous Professional Education
Email: ger-marin@yandex.ru
ORCID iD: 0000-0003-2179-8421
PhD, Professor of the Department of Epidemiology
Russian Federation, MoscowEvgeniya A. Medvedeva
A.I. Yevdokimov Moscow State University of Medicine and Dentistry
Email: evgeniya0103med@yandex.ru
ORCID iD: 0000-0001-7786-3777
PhD, Assistant of the Department of Propaedeutics of Internal Diseases and Gastroenterology
Russian Federation, MoscowReferences
- Nägele MP, Haubner B, Tanner FC, et al. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atherosclerosis. 2020;314:58-62. https://doi.org/10.1016/j.atherosclerosis.2020.10.014
- Perico L, Benigni A, Casiraghi F, et al. Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nat Rev Nephrol. 2021;17(1):46-64. https://doi.org/10.1038/s41581-020-00357-4
- Portier I, Campbell RA, Denorme F. Mechanisms of immunothrombosis in COVID-19. Curr Opin Hematol. 2021;28(6):445-453. https://doi.org/10.1097/MOH.0000000 000000666
- Kvietys PR, Fakhoury HMA, Kadan S, et al. COVID-19: Lung-Centric Immunothrombosis. Front Cell Infect Microbiol. 2021;11:679878. https://doi.org/10.3389/fcimb.2021.679878
- Bonaventura A, Vecchié A, Dagna L, et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021;21(5):319-329. https://doi.org/10.1038/s41577-021-00536-9
- Sukumar K, Tadepalli A. Nexus between COVID-19 and periodontal disease. J Int Med Res. 2021;49(3):30006052 11002695. https://doi.org/10.1177/03000605211002695
- Kadkhodazadeh M, Amid R, Moscowchi A. Does COVID-19 Affect Periodontal and Peri-Implant Diseases? J Long Term Eff Med Implants. 2020;30(1):1-2. https://doi.org/10.1615/JLongTermEffMedImplants.2020034882
- Campisi G, Bizzoca ME, Lo Muzio L. COVID-19 and periodontitis: reflecting on a possible association. Head Face Med. 2021;17(1):16. https://doi.org/10.1186/s13005-021-00267-1
- Elisetti N. Periodontal pocket and COVID-19: Could there be a possible link? Med Hypotheses. 2021;146:110355. https://doi.org/10.1016/j.mehy.2020.110355
- Badran Z, Gaudin A, Struillou X, et al. Periodontal pockets: A potential reservoir for SARS-CoV-2? Med Hypotheses. 2020;143:109907. https://doi.org/10.1016/j.mehy.2020.109907
- Ting M, Suzuki JB. SARS-CoV-2: Overview and Its Impact on Oral Health. Biomedicines. 2021;9(11):1690. https://doi.org/10.3390/biomedicines9111690
- Okada Y, Yoshimura K, Toya S, Tsuchimochi M. Pathogenesis of taste impairment and salivary dysfunction in COVID-19 patients. Jpn Dent Sci Rev. 2021;57:111-122. https://doi.org/10.1016/j.jdsr.2021.07.001
- Matuck BF, Dolhnikoff M, Duarte-Neto AN, et al. Salivary glands are a target for SARS-CoV-2: a source for saliva contamination. J Pathol. 2021;254(3):239-243. https://doi.org/10.1002/path.5679
- Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. International Journal of Oral Science. 2020;12(1):8. https://doi.org/10.1038/s41368-020-0074-x
- El Kady DM, Gomaa EA, Abdella WS, et al. Oral manifestations of COVID-19 patients: An online survey of the Egyptian population. Clin Exp Dent Res. 2021;7(5):852-860. https://doi.org/10.1002/cre2.429
- Makedonova YuA, Porojskij SV, Gavrikova LM, Afanaseva OYu. Manifestation of the oral mucosa diseases in patients with COVID-19. Vestnik VolGMU. 2021;1(77):110-115. (In Russ.). [Македонова Ю.А., Поройский С.В., Гаврикова Л.М., Афанасьева О.Ю. Проявление заболеваний слизистой полости рта у больных, перенесших COVID-19. Вестник ВолГМУ. 2021;1(77):110-115]. https://doi.org/10.19163/1994-9480-2021-1(77)-110-115
- Khabadze ZS, Sobolev KE, Todua IM, Mordanov OS. Changes in the oral mucosa and general indicators with COVID-19 (SARS-CoV-2): a single-center descriptive study. Endodontics Today. 2020;18(2):4-9. (In Russ.). [Хабадзе З.С., Соболев К.Э., Тодуа И.М., Морданов О.С. Изменения слизистой оболочки полости рта и общих показателей при COVID-19 (SARS-CoV-2): одноцентровое описательное исследование. Эндодонтия Today. 2020;18(2):4-9]. https://doi.org/10.36377/1683-2981-2020-18-2-4-9
Supplementary files
